Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio Linfomi - Wikidata - awgldk - TriplyDB

Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio Linfomi

Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio Linfomi

http://www.wikidata.org/entity/Q28186766

about

Spiro[pyrrolidine-3, 3´-oxindole] as potent anti-breast cancer compounds: Their design, synthesis, biological evaluation and cellular target identification Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up Yeast factories for the production of aromatic compounds: from building blocks to plant secondary metabolites.Tumour burden at diagnosis as the main clinical predictor of cell resistance in patients with early stage, favourable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy.Functionalized Spiroindolines with Anticancer Activity through a Metal-Free Post-Ugi Diastereoselective One-Pot Cascade Reaction.

P2860

Q28828506-65272DD3-5F08-413B-B74C-0BAF87087E12 Q37146056-E2EC7A94-9153-4026-AB03-A9F6A2A122D0 Q38942796-580BA4DC-DA8C-48AF-BDF6-34D6E5BDD51A Q45133878-92F8D538-72E2-4D8A-84AE-2A77D2ED9BD5 Q52575310-E4D0848F-D3D7-452F-87D0-297344DD3ACF

P2860

Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio Linfomi

http://www.wikidata.org/entity/Q28186766

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Vinblastine, bleomycin, and me ...... Gruppo Italiano Studio Linfomi

@ast

Vinblastine, bleomycin, and me ...... Gruppo Italiano Studio Linfomi

@en

Vinblastine, bleomycin, and me ...... Gruppo Italiano Studio Linfomi

@nl

type

label

Vinblastine, bleomycin, and me ...... Gruppo Italiano Studio Linfomi

@ast

Vinblastine, bleomycin, and me ...... Gruppo Italiano Studio Linfomi

@en

Vinblastine, bleomycin, and me ...... Gruppo Italiano Studio Linfomi

@nl

prefLabel

Vinblastine, bleomycin, and me ...... Gruppo Italiano Studio Linfomi

@ast

Vinblastine, bleomycin, and me ...... Gruppo Italiano Studio Linfomi

@en

Vinblastine, bleomycin, and me ...... Gruppo Italiano Studio Linfomi

@nl

P1433

Q28186766-D9E98A5D-CD0A-413F-832C-C56BA9300A5F

P1476

Q28186766-A5C773D7-8636-4DEF-9085-A61334290988

P2093

Q28186766-0D98C3D7-F6FD-4CBB-B287-B0CD4A5AEBE9

Q28186766-112C5DFF-0A1A-4E36-AF6E-0B233D40335E

Q28186766-68244C65-797F-4091-AF8C-2C5C31CCAE21

Q28186766-6AA47961-D1E0-418C-A64E-41FECF090767

Q28186766-6B0E1626-2833-4DD4-BF6A-70812EDCFDEB

Q28186766-86609D82-D0B9-4E2D-9DDD-280B1195020F

Q28186766-90B4DB60-D589-43C2-9053-AA39603C7787

Q28186766-938F8F98-1842-4488-8F71-A6C0079EBA36

Q28186766-962B4D10-6EC5-49B0-95AD-B80F63A88F7E

Q28186766-B63983C7-DE40-40B9-AE7F-DA16AFBFDE7A

P2860

Q28186766-60A79361-4C04-4AA7-89B5-C9CE735F5BFF

Q28186766-6E7C7514-3CBC-401D-86D2-EF88B212BBF0

Q28186766-B6A9A8BF-D5F3-4E95-A384-B42E948EE070

Q28186766-CA5E28C2-2C62-4D2A-9481-EB69E1E7FBD0

Q28186766-D5619263-CD78-42CD-848E-DA57ADB09DFB

Q28186766-E4544897-A2CB-40F4-B7CB-4728D1875B38

Q28186766-EFB468B1-F410-4933-8B13-64D014477B92

Q28186766-F3B67930-6F69-433F-9A7F-E53C625D94C9

P304

Q28186766-EFC43059-6FC5-43F6-8AC4-9082B011A68D

P31

Q28186766-4DC91B4F-CD4F-4048-A550-5A4C5F8621E8

P356

Q28186766-13F6B36F-5183-4AD3-9734-BB2DA4E3E857

P407

Q28186766-89A80F8F-8BC7-4B40-A42E-69C82345134D

P433

Q28186766-2AD98D27-6923-4713-A63C-F077ACEF6100

P478

Q28186766-65FA59DC-5A70-4836-9D28-B10307CFAA9A

P577

Q28186766-082869F7-37C5-4E2D-AC5C-80EB75B1848E

P5875

Q28186766-10459F19-FA64-4ACD-9007-74009B708A82

P698

Q28186766-BA5C3D14-C5A8-4759-A14E-A80AED30407F

P921

Q28186766-7D3AA2C7-E69C-4CF1-A35D-B5074CC9B0C2

P356

P1433

P1476

Vinblastine, bleomycin, and me ...... Gruppo Italiano Studio Linfomi

@en

P2093

Carla Cavalli

http://www.w3.org/2001/XMLSchema#string

Caterina Stelitano

http://www.w3.org/2001/XMLSchema#string

Chiara Broglia

http://www.w3.org/2001/XMLSchema#string

Dimitri Luisi

http://www.w3.org/2001/XMLSchema#string

Edoardo Ascari

http://www.w3.org/2001/XMLSchema#string

Emilio Iannitto

http://www.w3.org/2001/XMLSchema#string

Francesco Merli

http://www.w3.org/2001/XMLSchema#string

Laura Dezza

http://www.w3.org/2001/XMLSchema#string

Massimo Federico

http://www.w3.org/2001/XMLSchema#string

Matteo Dell'Olio

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

Should poor risk patients with Hodgkin's disease be sorted out for intensive treatments?

Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease.

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.

Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation.

Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: the Gruppo Italiano per lo Studio dei Linfomi Experience.

P304

2393-401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.11807

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8993555

http://www.w3.org/2001/XMLSchema#string

P698

14635074

http://www.w3.org/2001/XMLSchema#string

P921